Injectable collagen for soft tissue augmentation.
Abstract
Collagen from allogenic and xenogeneic sources has been made soluble by controlled proteolytic digestion. The monomeric, telopeptide-poor collagen so prepared forms a cohesive mass when warmed to body temperature (upon injection), creating a structural basis for new soft connective tissue. We have treated 28 patients with human and/or bovine collagen injections for the correction of soft tissue contour defects, and we have followed them for 3 to 18 months. In most instances, there has been lasting and substantial correction of the defects treated. The complications have been few and transient.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | soft tissue
|
scispacy | 1 | ||
| 해부 | soft connective tissue
|
scispacy | 1 | ||
| 기타 | collagen
|
scispacy | 1 | ||
| 기타 | telopeptide-poor collagen
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | human
|
scispacy | 1 | ||
| 기타 | bovine collagen
|
scispacy | 1 |
MeSH Terms
Acne Keloid; Animals; Cattle; Cellulitis; Collagen; Female; Folliculitis; Follow-Up Studies; Humans; Injections, Intradermal; Injections, Subcutaneous; Male; Pigmentation Disorders; Rats; Skin Diseases; Surgery, Plastic; Transplantation, Homologous; Urticaria